The Latest From CureMatch
Precision medicine is revolutionizing cancer care. Dr. Razelle Kurzrock highlights how personalized treatments improve patient outcomes and quality of life. Plus, it’s enrollment season! Get the information you need for Medicare enrollment in this week’s conversation with Samantha Smith from the Patients Rising Concierge. And as November marks Lung Cancer Awareness Month, Terry and Dr. […]
Scientists from CureMatch and UCSD use pharmacophore-based drug design and a molecular docking technique to identify candidate protease inhibitors for COVID-19 SAN DIEGO, CA – April 15, 2020 – CureMatch, a digital health company focusing on personalized medicine and combination therapies, today announced that Chief Science Officer and Co-Founder, Dr. Igor Tsigelny, along with Dr. […]
Navid Alipour, founder of our parent company, Analytics Ventures, was interviewed by AI Trends regarding the challenges of using artificial intelligence in healthcare–and how we at CureMatch are working to solve those challenges. Read the full article here.
CureMatch is pleased to announce our win at MedTech Insight Awards 2019 in the category of Best Technological Innovation: Digital. The judges explained their choice by describing the platform as “An exciting technology that has the potential to transform how cancer care is delivered. What an excellent use of data, and a well-deserved winning entry […]
SAN DIEGO, CA – July 22, 2019 – CureMatch is pleased to announce the hire of Yekaterina Khotskaya as vice president of clinical operations. As head of CureMatch’s clinical operations, Dr. Khotskaya will bring her experience in research, software development, project management, and molecular diagnostics to work hand in hand with clinicians to bring CureMatch’s […]